Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions
This study has been completed.
Sponsor:
Par Pharmaceutical, Inc.
Collaborator:
Algorithme Pharma Inc
Information provided by:
Par Pharmaceutical, Inc.
ClinicalTrials.gov Identifier:
NCT00659685
First received: April 10, 2008
Last updated: April 15, 2008
Last verified: March 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |